See how your reported results read as versioned evidence records — linked to experiments and limitations.Know what the science actually supports before you trust the answer.
Press Enter ↵ to review claims
Explore by Goal
"If you thought that science was certain - well, that is just an error on your part."
- Richard Feynman
Quick Explanation
Copied
Concise assessment — Anna Hayman Robertson
Anna Hayman Robertson is a mid-career, public-health/medical researcher with substantial recent output on vaccine safety, SARS‑CoV‑2 immunology/transmission, and vaccine-related menstrual/bleeding outcomes; OpenAlex records 33 works, h-index 14 and 471 citations (2026 snapshot) and multiple peer-reviewed coauthored papers in high-quality journals (Nature Communications, Vaccine, The Journal of Infectious Diseases, BMC Infectious Diseases) supporting those topical areas.
Key evidence: papers on Omicron breakthrough immunity, menstrual changes after COVID-19 vaccination, household transmission of Alpha, influenza pregnancy outcomes, and booster effectiveness — all peer‑reviewed and many open-access.
Long Explanation
Author Review — Anna Hayman Robertson (evidence‑based)
Visual: publication activity & citations by year (OpenAlex counts)
OpenAlex metrics (2026 snapshot): 33 works, 471 citations, h-index 14 (counts_by_year show concentrated activity 2021–2025) — indicates substantial recent productivity and citation impact for a mid-career researcher; details below.
Top-topic areas: COVID-19 immunology/transmission, vaccine safety (incl. menstrual/bleeding outcomes), influenza/pregnancy outcomes; these are supported by multiple peer‑reviewed publications listed below.
Publication venues: Nature Communications, Vaccine, The Journal of Infectious Diseases, BMC Infectious Diseases, Microorganisms, Frontiers in Immunology and The Lancet Healthy Longevity — a mix of high-to-respectable journals.
Primary evidence (examples):
Critical appraisal — strengths and limitations
Strengths
Rapid, topical research program addressing pressing public‑health questions (COVID transmission, vaccine safety, immune responses) with multiple coauthored papers in strong journals — indicates productive collaborations and access to good datasets/registries.
Frequent use of population registries/cohort methods and immunological assays (in collaborations) — methods appropriate to the questions addressed.
Open access for many studies — enhances reproducibility and transparency.
Limitations / blind spots
Many publications are large multi‑author team science; author position is often middle — difficult to parse leadership/independence from provided metadata alone.
Evidence mostly observational (cohorts, registries) for vaccine-safety and VE work — subject to confounding, healthy‑user bias, and temporal changes in circulating variants; most papers discuss limitations but mechanistic causal claims remain limited.
Topic focus is heavily epidemiologic/public-health — less evidence of bench (mechanistic) leadership or first‑author basic‑science breakthroughs in the extracted record.
Overall, evidence‑weighted conclusion
Anna Hayman Robertson has built a solid, collaborative body of public‑health research with demonstrable topical impact on vaccine safety, COVID‑19 immunology/transmission and pregnancy/influenza outcomes; citation trajectory and choice of journals indicate good visibility and influence in applied epidemiology and vaccine safety. Robustness is moderate-to-strong for observational epidemiology (good sample sizes, registries) but mechanistic causal claims require further targeted lab/experimental follow-up.
Representative supporting citations are embedded above for verification.
Key primary citations used (examples):
Feedback:
Updated: March 16, 2026
BGPT Author Review
Scientific Quality
70%
Solid, mid‑career applied epidemiologist/public‑health scientist: high recent productivity on topical issues (COVID‑19, vaccine safety) with multiple coauthored papers in respected journals; evidence quality is generally moderate-to-strong for observational epidemiology but limited direct evidence of independent leadership of basic-mechanistic discoveries. Metrics (OpenAlex: 33 works, h-index 14, 471 citations) show meaningful impact but not yet at the highest field-leading level.
Communication Quality
80%
Clear presentation in peer-reviewed journals and frequent use of open-access and public-health reporting conventions; papers typically include transparent methods, limitations and are accessible to public-health audiences. Middle-author roles slightly reduce clarity about individual communication leadership.
Author Novelty
60%
Research topics are highly relevant but not highly novel in conceptual terms (epidemiologic studies, vaccine safety assessment) — novelty arises from timeliness, population-scale data, and variant-specific findings rather than paradigm-shifting mechanistic theory.
Scientific Rigor
70%
Most publications use appropriate observational and immunologic methods (cohort designs, registry linkage, neutralization assays); studies acknowledge confounders and limitations. Rigor is good for epidemiology but further mechanistic validation would increase overall rigor.
Preparing reproducible author-level bibliometrics: the script will fetch OpenAlex author ID records, parse works_count/h_index/citations_by_year, and create yearly figures for trend analysis.
Get emailed when your analysis is done!
We'll email you the results when your analysis is finished.
Hypothesis Graveyard
Hypothesis: Middle-author status implies low intellectual contribution — falsified: many large cohort studies rely on distributed roles; contribution cannot be inferred solely from author order.
Hypothesis: Observational signals equal causation — falsified: authors and cited papers explicitly treat observational associations as hypothesis-generating and acknowledge confounding.
Quick Explanation
Long Explanation
Analysis Wizard
Hypothesis Graveyard
Potential Experiments
Discussion
Explore by Goal
Ask a Follow-Up
Key Insight
Keep Exploring
